85.55
price up icon0.14%   0.12
pre-market  Pre-market:  84.56   -0.99   -1.16%
loading

Haemonetics Corp Stock (HAE) Forecast

The Haemonetics Corp (HAE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $115.83, representing a +35.40% increase from the current price of $85.55. The highest analyst price target is $118.78, and the lowest is $112.88.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HAE Price Target
Average 90.35 (+5.62% Upside)
loading

Is Haemonetics Corp (HAE) A Buy Now?

Oscillators
Name Value Action
RSI(14) 57.69 Neutral
STOCH(9,6) 33.25 Neutral
STOCHRSI(14) 23.16 Neutral
MACD(12,26) 2.8156 Sell
ADX(14) 28.05 Buy
William %R -43.35 Neutral
CCI(14) -19.96 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
88.54
Sell
85.94
Sell
MA20
82.48
Buy
83.80
Buy
MA50
78.76
Buy
80.70
Buy
MA100
80.16
Buy
80.59
Buy
MA200
82.01
Buy
82.11
Buy
Buy: 8 Sell: 2 Neutral: 0
Summary: Buy
According to our latest analysis, HAE could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 3 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on HAE, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 57.69 indicates that HAE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 33.25 indicates that HAE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 23.16 indicates that HAE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 28.05 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -19.96 indicates that HAE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term HAE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Haemonetics Corp financial reports and earnings history, Haemonetics Corp (HAE) stock could reach $103.08 by 2030, $72.55 by 2040 and $37.20 by 2050. See the projected annual prices until 2050 of the Haemonetics Corp stock below:

  • Haemonetics Corp (HAE) is expected to reach an average price of $72.84 in 2035, with a high prediction of $81.43 and a low estimate of $72.55. This indicates an $-14.85% rise from the last recorded price of $85.55.
  • Haemonetics Corp (HAE) stock is projected to chart a bullish course in 2040, with an average price target of $69.98, representing an $-18.20% surge from its current level. The forecast ranges from a conservative $67.15 to a sky-high $72.55.
  • Our analysts predict Haemonetics Corp (HAE) to jump -32.75% by 2045, soaring from $53.22 to an average price of $57.53, potentially reaching $61.03. While $53.22 is the low estimate, the potential upside is significant.
  • Haemonetics Corp (HAE) stock is expected to climb by 2050, reaching an average of $34.14, a $-60.09% jump from its current level. However, a wide range of estimates exists, with high and low targets of $37.20 and $28.38, respectively, highlighting the market's uncertainty.

Haemonetics Corp Stock (HAE) Year by Year Forecast

Haemonetics Corp Stock (HAE) Price Forecast for 2024

Our forecast for HAE stock price in 2024 now indicates an average price target of $103.18 with a high forecast of $135.61 and a low forecast of $70.74. The average prediction reflects an increase of +20.60% from the last recorded price of $85.55.
Month Average Low High Change from today's price
December, 2024 $116.86 $112.88 $118.78 +36.59%

Haemonetics Corp Stock (HAE) Price Forecast for 2025

Haemonetics Corp Stock (HAE) is expected to reach an average price of $90.35 in 2025, with a high prediction of $121.90 and a low estimate of $58.81. This indicates an +5.62% rise from the last recorded price of $85.55.
Month Average Low High Change from today's price
January, 2025 $110.27 $108.67 $116.69 +28.90%
February, 2025 $102.91 $101.05 $113.01 +20.30%
March, 2025 $101.87 $100.33 $121.90 +19.07%
April, 2025 $94.49 $58.81 $108.36 +10.44%
May, 2025 $102.92 $86.01 $103.32 +20.31%
June, 2025 $95.77 $90.99 $117.09 +11.94%
July, 2025 $80.28 $78.56 $108.81 -6.16%
August, 2025 $83.54 $78.61 $89.30 -2.34%
September, 2025 $75.08 $69.78 $89.02 -12.24%
October, 2025 $85.10 $73.79 $86.09 -0.52%
November, 2025 $82.55 $75.44 $90.09 -3.50%
December, 2025 $96.40 $82.26 $102.85 +12.68%

Haemonetics Corp Stock (HAE) Price Forecast for 2026

The predicted value for Haemonetics Corp (HAE) in 2026 is set at an average of $91.01. Estimates vary from a peak of $137.43 to a trough of $44.59, indicating an +6.38% surge from the present price of $85.55.
Month Average Low High Change from today's price
January, 2026 $109.04 $89.76 $115.29 +27.46%
February, 2026 $115.21 $105.79 $115.39 +34.68%
March, 2026 $120.98 $111.60 $125.24 +41.41%
April, 2026 $127.99 $106.68 $137.43 +49.60%
May, 2026 $109.28 $107.83 $128.56 +27.73%
June, 2026 $112.39 $104.87 $113.40 +31.37%
July, 2026 $51.33 $44.59 $115.21 -40.00%
August, 2026 $55.41 $49.81 $55.42 -35.24%
September, 2026 $58.82 $53.46 $63.79 -31.25%
October, 2026 $53.81 $52.25 $59.38 -37.10%
November, 2026 $58.10 $51.98 $59.37 -32.09%
December, 2026 $65.92 $57.90 $67.04 -22.95%

Haemonetics Corp Stock (HAE) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Haemonetics Corp (HAE) is $55.67, with a high forecast of $72.47 and a low forecast of $38.86. This indicates an -34.93% decrease from the last price of $85.55.
Month Average Low High Change from today's price
January, 2027 $67.13 $61.38 $68.07 -21.53%
February, 2027 $51.53 $50.50 $70.70 -39.77%
March, 2027 $48.48 $44.69 $51.76 -43.33%
April, 2027 $48.05 $44.94 $50.54 -43.83%
May, 2027 $41.98 $38.86 $48.08 -50.93%
June, 2027 $53.72 $41.33 $55.03 -37.21%
July, 2027 $58.59 $46.89 $58.82 -31.51%
August, 2027 $49.39 $49.29 $59.64 -42.27%
September, 2027 $59.54 $44.05 $60.11 -30.40%
October, 2027 $56.15 $53.61 $61.63 -34.36%
November, 2027 $62.19 $55.91 $63.72 -27.31%
December, 2027 $70.59 $58.20 $72.47 -17.49%

Haemonetics Corp Stock (HAE) Price Forecast for 2028

In 2028, Haemonetics Corp (HAE) is projected to reach an average price of $76.92, with a high projection of $86.80 and a low estimate of $67.03. This indicates an -10.09% fall from the last price of $85.55.
Month Average Low High Change from today's price
January, 2028 $69.13 $67.77 $72.99 -19.19%
February, 2028 $69.43 $67.03 $74.85 -18.85%
March, 2028 $80.35 $68.54 $80.80 -6.08%
April, 2028 $78.96 $70.49 $81.88 -7.70%
May, 2028 $74.59 $71.41 $81.99 -12.81%
June, 2028 $84.73 $67.67 $84.75 -0.96%
July, 2028 $75.99 $74.80 $86.80 -11.17%
August, 2028 $70.77 $70.19 $79.05 -17.28%
September, 2028 $77.75 $69.55 $80.27 -9.11%
October, 2028 $77.68 $75.53 $81.70 -9.20%
November, 2028 $83.56 $76.02 $85.08 -2.33%
December, 2028 $80.57 $78.06 $84.40 -5.82%

Haemonetics Corp Stock (HAE) Price Forecast for 2029

The 2029 price forecast for Haemonetics Corp Stock (HAE) is $78.45 on average, with a high prediction of $90.70 and a low estimate of $66.20. This represents an -8.30% decrease from the previous price of $85.55.
Month Average Low High Change from today's price
January, 2029 $87.68 $77.57 $89.96 +2.49%
February, 2029 $83.92 $79.77 $90.70 -1.91%
March, 2029 $85.55 $82.09 $87.32 +0.00%
April, 2029 $84.81 $81.21 $89.03 -0.87%
May, 2029 $81.57 $77.57 $87.59 -4.65%
June, 2029 $79.71 $75.42 $85.98 -6.82%
July, 2029 $80.97 $77.10 $85.57 -5.36%
August, 2029 $71.92 $71.70 $81.46 -15.93%
September, 2029 $68.97 $66.20 $76.96 -19.38%
October, 2029 $75.75 $67.46 $76.84 -11.46%
November, 2029 $76.71 $75.62 $82.81 -10.33%
December, 2029 $87.37 $76.37 $90.19 +2.13%

Haemonetics Corp Stock (HAE) Price Forecast for 2030

Haemonetics Corp Stock (HAE) is expected to reach an average price of $92.48 in 2030, with a high forecast of $130.87 and a low forecast of $54.09. This signifies an +8.10% surge from the last price of $85.55.
Month Average Low High Change from today's price
January, 2030 $102.84 $84.33 $103.08 +20.21%
February, 2030 $112.87 $101.35 $113.49 +31.94%
March, 2030 $112.29 $110.47 $116.16 +31.26%
April, 2030 $123.24 $106.31 $130.87 +44.06%
May, 2030 $117.20 $106.44 $123.77 +37.00%
June, 2030 $110.24 $109.87 $120.64 +28.86%
July, 2030 $109.21 $108.15 $121.28 +27.66%
August, 2030 $107.65 $105.68 $113.71 +25.83%
September, 2030 $106.49 $103.94 $109.48 +24.48%
October, 2030 $111.53 $96.33 $117.17 +30.37%
November, 2030 $80.10 $76.01 $112.25 -6.37%
December, 2030 $88.04 $54.09 $95.27 +2.91%
$20.78
price up icon 2.06%
$225.89
price down icon 1.02%
medical_instruments_supplies BAX
$33.21
price up icon 0.67%
$78.97
price up icon 0.32%
medical_instruments_supplies COO
$100.80
price up icon 0.89%
medical_instruments_supplies WST
$316.59
price down icon 1.34%
Cap:     |  Volume (24h):